Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 10Specimen Handling 9Cisplatin 7pembrolizumab 4Radiation 4Platinum 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Cetuximab 3toripalimab 2cemiplimab 2Interviews as Topic 2Docetaxel 2Chemoradiotherapy 2Carboplatin 2sacituzumab govitecan 1merphos 1ipatasertib 1cobimetinib 1cabozantinib 1X-Rays 1Vemurafenib 1Tretinoin 1Transurethral Resection of Bladder 1Taxes 1Surveys and Questionnaires 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Laryngeal Neoplasms × Hearing × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡